Olverembatinib
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Olverembatinib, covering 2022-07-29 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia [Phase 1]